News

Hilleman Laboratories is committed to developing high impact, affordable vaccines for people in developing countries in an innovative and sustainable manner.

Hilleman Laboratories Pvt. Ltd, India, Vaccine Asia Pacific 2015

Date: 13/10/2015

Hilleman Laboratories Pvt. Ltd, India, Vaccine Asia Pacific 2015

How promising is the development of a semi-synthetic meningococcal conjugate vaccine? - a case study 5thAsia Pacific Global Summit and Expo on Vaccines & Vaccination

View All